Top Analyst Upgrades and Downgrades: IBM, Lennar, Regions, Shake Shack, Shopify, TerraForm, McDonald’s and Many More

Print Email

AstraZeneca PLC (NYSE: AZN) was raised to Equal Weight from Underweight at Barclays. The stock closed at $30.59, within a 52-week range of $29.50 to $36.69.

Cerulean Pharma Inc. (NASDAQ: CERU) was reiterated as Buy at Janney Capital Markets with a roughly a $9.00 enterprise value, much higher than the $2.41 close. Janney noted it is high speculative despite targeting the end of times for cytotoxic chemotherapy — and unlikely to be profitable until 2021. Cerulean has a 52-week range of $2.28 to $10.87, showing just how volatile it is.

China Mobile Ltd. (NYSE: CHL) was raised to Buy from Hold at Deutsche Bank.

Citigroup Inc. (NYSE: C) was maintained as Outperform at RBC Capital Markets, but the firm did lower its target price to $60 from $65.

CSX Corp. (NYSE: CSX) was maintained as Buy at Argus, but the price target was cut to $28 from $37.

Diana Shipping Inc. (NYSE: DSX) was maintained as Hold at Jefferies, but the price target was cut to $2.50 from $5.50 in the call.

Freshpet Inc. (NASDAQ: FRPT) was maintained as Buy at Canaccord Genuity, but the firm lowered its price target to $9 from $11.


Intrepid Potash Inc. (NYSE: IPI) was raised to Sector Perform from Underperform at Scotia Capital.

McCormick & Co. (NYSE: MKC) was downgraded to Underweight from an already cautious Neutral rating, and the price target was cut to $76 from $82 (versus an $83.71 close) at JPMorgan.

NetApp Inc. (NASDAQ: NTAP) was maintained as Hold at Jefferies, but the firm lowered its price target to $23.00 from $31.00.

Nordic American Tanker Shipping Ltd. (NYSE: NAT) was maintained as Hold at Jefferies, but the price target was cut to $12.00 from $15.00.

Progressive Corp. (NYSE: PGR) was downgraded to Market Perform from Outperform with a $33 price target (versus a $29.91 close) at Bernstein.

ResMed Inc. (NYSE: RMD) was downgraded to Underweight from Equal Weight and the price target was cut to $52 from $61 at Barclays.

Sarepta Therapeutics Inc. (NASDAQ: SRPT) was downgraded to Sector Perform from Outperform with a $15 price target (versus a $14.28 close) at RBC Capital Markets.

Scorpio Bulkers Inc. (NYSE: SALT) was maintained as Buy at Jefferies, but the firm slashed its price target to $10.00 from $36.00.

Scorpio Tankers Inc. (NYSE: STNG) was maintained as Buy at Jefferies, but the price target was cut to $10.00 from $12.00.

Silgan Holdings Inc. (NASDAQ: SLGN) was raised to Outperform from Market Perform at Wells Fargo.

Star Bulk Carriers Corp. (NASDAQ: SBLK) was maintained as Buy at Jefferies, but the price target was cut to $1.00 from $4.00.

St. Jude Medical Inc. (NYSE: STJ) was downgraded to Market Perform from Outperform at Wells Fargo.

Sunstone Hotel Investors Inc. (NYSE: SHO) was raised to Buy from Hold with a $12.50 price target (versus a $10.32 close) at Evercore ISI.

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) was reiterated as Buy with a $126 price target (versus a $79.63 close) at Canaccord Genuity.

Wells Fargo & Co. (NYSE: WFC) was maintained as Buy at Argus, but the price target was cut to $58 from $63.

If you missed out on Friday’s top analyst upgrades and downgrades, they were in shares of Best Buy, 3D Systems, EA, Gilead, Nokia, Shire, United Rentals and over a dozen more.